Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants-Reference-Cited by-同舟云学术

Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants

Published:2022-01-07 Issue:1 Volume:11 Page:212-226
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Fan Shengtao¹,Xiao Kang²,Li Dandan¹,Zhao Heng¹,Zhang Jingjing¹,Yu Li¹,Chang Penglan¹,Zhu Shuangli²,Xu Xingli¹,Liao Yun¹,Ji Tianjiao²,Jiang Guorun¹,Yan Dongmei²,Zeng Fengyuan¹,Duan Suqin¹,Xia Baicheng²,Wang Lichun¹,Yang Fengmei¹,He Zhanlong¹^ORCID,Song Yang²,Cui Pingfang¹,Li Xiaolei²,Zhang Yaxing¹,Zheng Bangyi¹,Zhang Ying¹,Xu Wenbo²,Li Qihan¹

Affiliation:

1. Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China

2. National Institute for Viral Disease Control and Prevention, China CDC, Beijing, 102206, China

Funder

The National Key R&D Program of China

Applied Basic Research Key Project of Yunnan, China

The Program of Chinese Academy of Medicine Science, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2021.2021807

Reference37 articles.

1. Johns_Hopkins_University. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU). 2020. http://publichealthupdate.com/jhu/.

2. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

3. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

4. SARS-CoV-2 variants, spike mutations and immune escape

5. The variant gambit: COVID-19’s next move

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein;Vaccines;2023-05-09

2. Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques;Vaccine;2023-04

3. Vaccine selection for COVID-19 by AHP and novel VIKOR hybrid approach with interval type-2 fuzzy sets;Engineering Applications of Artificial Intelligence;2023-03

4. Method of obtaining purified SARS-CoV-2 antigen for structural and immunological studies in whole-virion vaccines against coronavirus infection;Medical academic journal;2022-11-06

5. Evaluation of humoral immune responses induced by different SARS‐CoV‐2 spike trimers from wild‐type and emerging variants with individual, sequential, and combinational delivered strategies;Journal of Medical Virology;2022-08-29